[{"address1": "2000 Frontis Plaza Blvd.", "address2": "Suite 250", "city": "Winston-Salem", "state": "NC", "zip": "27103", "country": "United States", "phone": "336 999 7028", "website": "https://www.prokidney.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases in the United States. The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture, which has completed Phase I clinical trial for REACT in patients with congenital anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease. ProKidney Corp. founded in 2015 and is headquartered in Winston-Salem, North Carolina.", "fullTimeEmployees": 163, "auditRisk": 10, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 8, "governanceEpochDate": 1717200000, "maxAge": 86400, "priceHint": 4, "previousClose": 2.56, "open": 2.6, "dayLow": 2.4101, "dayHigh": 2.61, "regularMarketPreviousClose": 2.56, "regularMarketOpen": 2.6, "regularMarketDayLow": 2.4101, "regularMarketDayHigh": 2.61, "beta": 1.401, "forwardPE": -3.6764705, "volume": 592572, "regularMarketVolume": 592572, "averageVolume": 990312, "averageVolume10days": 1708960, "averageDailyVolume10Day": 1708960, "bid": 2.46, "ask": 2.53, "bidSize": 300, "askSize": 100, "marketCap": 1819102592, "fiftyTwoWeekLow": 1.12, "fiftyTwoWeekHigh": 13.51, "fiftyDayAverage": 2.9102, "twoHundredDayAverage": 2.45225, "currency": "USD", "enterpriseValue": 1295858048, "floatShares": 44273868, "sharesOutstanding": 121840000, "sharesShort": 9890464, "sharesShortPriorMonth": 11559104, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.1547, "heldPercentInsiders": 0.23313, "heldPercentInstitutions": 0.28785, "shortRatio": 8.38, "shortPercentOfFloat": 0.1868, "impliedSharesOutstanding": 173380000, "bookValue": -17.787, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -35295000, "trailingEps": -0.57, "forwardEps": -0.68, "enterpriseToEbitda": -8.839, "52WeekChange": -0.7484909, "SandP52WeekChange": 0.26238096, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PROK", "underlyingSymbol": "PROK", "shortName": "ProKidney Corp.", "longName": "ProKidney Corp.", "firstTradeDateEpochUtc": 1625059800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "3961f41a-d4d9-3be3-908e-9fbc978e0b0e", "messageBoardId": "finmb_598380790", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.5, "targetHighPrice": 6.0, "targetLowPrice": 3.0, "targetMeanPrice": 4.83, "targetMedianPrice": 5.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 328998016, "totalCashPerShare": 5.147, "ebitda": -146599008, "totalDebt": 5951000, "quickRatio": 17.144, "currentRatio": 17.624, "debtToEquity": 1.639, "returnOnAssets": -0.21339001, "returnOnEquity": -0.31722, "freeCashflow": -85895128, "operatingCashflow": -98723000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]